← Moderna, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net loss ($216.2m) ($255.9m) ($384.7m) ($514.0m) ($747.1m) $12.2b $8.4b ($4.7b) ($3.6b) ($2.8b)
Net Income (Loss) Attributable to Parent — ($255.9m)
($384.7m) -50.34%
($514.0m) -33.60%
($747.1m) -45.34%
$12.2b +1733.33%
$8.4b -31.47%
($4.7b) -156.37%
($3.6b) +24.46%
($2.8b) +20.75%
Net Income (Loss) Available to Common Stockholders, Basic — ($269.8m)
($401.9m) -48.92%
($514.0m) -27.91%
($747.1m) -45.34%
— — — — —
Depreciation, Depletion and Amortization $15.1m $20.5m $24.9m $31.0m $31.3m $232.0m $348.0m $617.0m $185.0m $211.0m
Other Depreciation and Amortization — — — — — — — $621.0m $189.0m $215.0m
Amortization/accretion of investments $2.5m $1.1m ($1.9m) ($3.7m) $10.2m $54.0m $31.0m ($61.0m) ($95.0m) ($67.0m)
Deferred Income Tax Expense (Benefit) — $0 $0 ($1.2m) $0 ($296.0m) ($578.0m) $901.0m ($1.0m) $10.0m
Share-based Payment Arrangement, Noncash Expense — $40.1m $72.6m $81.1m $93.0m $142.0m $226.0m $305.0m $429.0m $483.0m
Share-based Payment Arrangement, Expense — $40.1m $72.6m $81.1m $93.0m $142.0m $226.0m $305.0m $429.0m $483.0m
Stock-based compensation $39.4m $40.1m $72.6m $81.1m $93.0m $142.0m $226.0m $305.0m $429.0m $483.0m
Other Nonoperating Income (Expense) — ($1.9m) $1.8m ($7.5m) ($6.1m) ($29.0m) ($45.0m) ($124.0m) ($87.0m) ($8.0m)
Loss on equity investments, net — — — — — $0 $0 $35.0m $52.0m $8.0m
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions — — — — — — — ($35) ($52) ($8)
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable — ($1.5m) ($195k) ($6.7m) $1.4b $1.8b ($1.8b) ($493.0m) ($534.0m) ($156.0m)
Accounts receivable, net ($8.6m) $1.5m $195k $6.7m ($1.4b) ($1.8b) $1.8b $493.0m $534.0m $156.0m
Increase (Decrease) in Inventories — — — — $46.5m $1.4b ($492.0m) ($747.0m) ($83.0m) $34.0m
Inventory Write-down — — — — — — $1.3b $2.2b $495.0m $291.0m
Inventory — — $0 $0 ($46.5m) ($1.4b) $492.0m $747.0m $83.0m ($34.0m)
Increase (Decrease) in Accounts Payable — ($12.8m) $15.0m ($24.0m) $11.9m $204.0m $240.0m $13.0m ($69.0m) ($92.0m)
Accounts payable $6.0m ($12.8m) $15.0m ($24.0m) $11.9m $204.0m $240.0m $13.0m ($69.0m) ($92.0m)
Purchases of property, plant and equipment included in accounts payable and accrued liabilities $10.0m $20.0m $12.9m $4.7m $17.6m $111.0m $72.0m $130.0m $97.0m $83.0m
Accrued liabilities $5.3m $34.4m $8.8m ($3.4m) $388.4m $989.0m $612.0m ($340.0m) ($385.0m) ($2.0m)
Deferred revenue $164.1m ($162.3m) ($65.3m) ($44.1m) $3.8b $2.8b ($4.2b) ($2.1b) ($439.0m) $41.0m
Prepaid expenses and other assets ($7.9m) $579k ($5.3m) $9.8m ($241.0m) ($489.0m) ($1.7b) $974.0m $145.0m $153.0m
Other liabilities $2.0m ($145k) $910k ($6.2m) $6.0m $123.0m $88.0m $73.0m $78.0m ($6.0m)
Net Cash Provided by (Used in) Operating Activities $66.7m
($331.5m) -596.72%
($330.9m) +0.19%
($459.0m) -38.72%
$2.0b +541.64%
$13.6b +571.94%
$5.0b -63.43%
($3.1b) -162.60%
($3.0b) +3.66%
($1.9b) +37.65%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment ($33.1m) $58.4m $105.8m $31.6m $67.4m $284.0m $400.0m $707.0m $1.1b $192.0m
Gain (Loss) on Disposition of Property Plant Equipment — $0 ($891k) ($316k) ($238k) — — — — —
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded — — — — — — $0 $0 $0 $0
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale — $800.4m $783.4m $993.2m $1.1b $1.3b $3.2b $5.6b $5.6b $5.6b
Purchases of marketable securities ($1.4b) ($727.2m) ($1.2b) ($1.1b) ($3.0b) ($12.7b) ($11.4b) ($3.8b) ($6.5b) ($5.8b)
Proceeds from maturities of marketable securities $675.2m $800.4m $783.4m $993.2m $1.1b $1.3b $3.2b $5.6b $5.6b $5.6b
Proceeds from sales of marketable securities $133.7m $402.5m $177.0m $168.7m $214.7m $3.1b $3.5b $3.2b $4.0b $2.4b
Payments to Acquire Businesses, Net of Cash Acquired — — — — — — — $85.0m $0 $0
Net Cash Provided by (Used in) Investing Activities ($648.6m) $416.1m ($372.5m) ($14.9m) ($1.7b) ($8.5b) ($5.2b) $4.2b $1.9b $1.9b
Cash flows from financing activities:
Payments for Repurchase of Common Stock — — — — — $857.0m $3.3b $1.2b $0 $2.0m
Proceeds from Issuance of Common Stock — — — — $1.9b $0 $0 — — —
Proceeds from issuance of common stock through equity plans $11k $212k $1.4m $47.3m $179.6m $124.0m $65.0m $46.0m $66.0m $35.0m
Tax payments related to net share settlements on equity awards — — — $0 $0 ($857.0m) ($3.3b) ($1.2b) $0 ($2.0m)
Net Cash Provided by (Used in) Financing Activities $472.9m
$168k -99.96%
$1.2b +730163.10%
$51.1m -95.83%
$2.0b +3877.22%
($873.0m) -142.94%
($3.4b) -294.96%
($1.4b) +60.06%
$56.0m +104.07%
$593.0m +958.93%
Net increase (decrease) in cash, cash equivalents and restricted cash — $86.0m $522.9m ($422.8m) $2.4b $4.2b ($3.6b) ($289.0m) ($999.0m) $668.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect — — — ($422.8m) $2.4b $4.2b ($3.6b) ($289.0m) ($999.0m) $668.0m
Cash, cash equivalents and restricted cash, beginning of year — $147.6m $670.5m $247.7m $2.6b $6.9b $3.2b $2.9b $1.9b $2.6b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — $247.7m $2.6b $6.9b $3.2b $2.9b $1.9b $2.6b
Effect of changes in exchange rates on cash and cash equivalents — — — — — — — $0 $0 $2.0m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised — — — $47.2m $179.6m $112.0m $50.0m $25.0m $42.0m $17.0m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 $0 $3.0m $0 $8.5m $14.0m $25.0m $39.0m $24.0m $10.0m
Income Taxes Paid, Net $905k $398k $294k $416k $572k $480.0m $2.7b ($357.0m) $197.0m $26.0m
Additional Financial Items
Equity Securities, FV-NI, Realized Gain (Loss) — — — — — — — ($35.0m) ($52.0m) ($8.0m)
General and Administrative Expense — $64.7m $94.3m $109.6m $188.3m $567.0m $1.1b $1.5b $1.2b $1.0b
Goodwill — — — — — — — $52.0m $52.0m $52.0m
Income Tax Expense (Benefit) — ($80k) $326k ($695k) $2.6m $1.1b $1.2b $772.0m ($46.0m) $54.0m
Investment Income, Interest — $15.2m $27.0m $38.5m $24.7m $18.0m $200.0m $421.0m $425.0m $314.0m
Operating Expenses — $475.2m $548.3m $605.9m — — — — — —
Other non-cash items — — — — $0 $0 $28.0m $7.0m $60.0m $77.0m
Right-of-use assets, operating leases — — $0 ($5.7m) ($10.5m) ($58.0m) $21.0m ($605.0m) ($53.0m) $38.0m
Operating lease liabilities — — $0 $12.6m $11.8m $17.0m ($14.0m) $551.0m $28.0m ($21.0m)
Acquisition of business, net of cash acquired — — — — — $0 $0 ($85.0m) $0 $0
Purchase of intangible asset — — — — — — — $0 $0 ($10.0m)
Investment in convertible notes and equity securities — — — $0 $0 ($30.0m) ($40.0m) ($23.0m) $0 $0
Proceeds from credit facility — — — — — — — $0 $0 $600.0m
Payment of credit facility issuance costs — — — — — — — $0 $0 ($22.0m)
Changes in financing lease liabilities — — — $1.0m ($6.0m) ($140.0m) ($184.0m) ($270.0m) ($10.0m) ($18.0m)

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.